Non-immune factors in chronic rejection. Is there a role for hypolipemic drugs?

Ann Transplant. 1997;2(2):65-9.
No abstract available

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Apolipoproteins B / blood
  • Cardiovascular Diseases / etiology
  • Cholesterol / blood
  • Chronic Disease
  • Female
  • Graft Rejection / drug therapy*
  • Graft Rejection / immunology
  • Humans
  • Hypolipidemic Agents / therapeutic use*
  • Kidney / drug effects
  • Kidney / physiopathology
  • Kidney Transplantation / adverse effects
  • Kidney Transplantation / immunology*
  • Lipoproteins / blood
  • Lovastatin / therapeutic use*
  • Male
  • Middle Aged
  • Risk Factors

Substances

  • Apolipoproteins B
  • Hypolipidemic Agents
  • Lipoproteins
  • Cholesterol
  • Lovastatin